<html>
<head>
<title>Federal Register, Volume 90 Issue 225 (Tuesday, November 25, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 225 (Tuesday, November 25, 2025)]
[Notices]
[Pages 53329-53330]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-21074]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review, Special 
Emphasis Panel; Clinical and Translational Cancer Research.
    Date: December 19, 2025.
    Time: 9:00 a.m. to 6:00 p.m.

[[Page 53330]]

    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Shuli Xia, Ph.D., Scientific Review Officer, 
Cancer Therapeutics Branch, Center for Scientific Review, National 
Institutes of Health, 9609 Medical Center Drive, Room 7W236, 
Rockville, MD 20850, 240-276-5256, <a href="/cdn-cgi/l/email-protection#a9dac1dcc5c087d1c0c8e9c7c0c187cec6df"><span class="__cf_email__" data-cfemail="8dfee5f8e1e4a3f5e4eccde3e4e5a3eae2fb">[email&#160;protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: November 21, 2025.
Denise M. Santeufemio,
Supervisory Program Analyst, Office of Federal Advisory Committee 
Policy.
[FR Doc. 2025-21074 Filed 11-24-25; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>